Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment options in metastatic renal carcinoma: an embarrassment of riches.

× No keyword cloud information.

13 in total

1. New chemotherapy strategies and biological agents in the treatment of childhood ependymoma.

Authors: Karen D Wright; Amar Gajjar
Journal: Childs Nerv Syst Date: 2009-02-11 Impact factor: 1.475

Review 2. [Uro-oncology--update 2009].

Authors: T Otto
Journal: Urologe A Date: 2009-09 Impact factor: 0.639

3. Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer.

Authors: Scott T Tagawa; Himisha Beltran
Journal: Asian J Androl Date: 2011-08-22 Impact factor: 3.285

4. Nanoliter droplet vitrification for oocyte cryopreservation.

Authors: Xiaohui Zhang; Imran Khimji; Lei Shao; Hooman Safaee; Khanjan Desai; Hasan Onur Keles; Umut Atakan Gurkan; Emre Kayaalp; Aida Nureddin; Raymond M Anchan; Richard L Maas; Utkan Demirci
Journal: Nanomedicine (Lond) Date: 2011-12-21 Impact factor: 5.307

5. Toward a common therapeutic framework in castration-resistant prostate cancer: a model for urologic oncology and medical oncology interaction.

Authors: Ralph de Vere White; Primo N Lara
Journal: Urol Oncol Date: 2014-05 Impact factor: 3.498

6. Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck.

Authors: C Matuschek; E Bölke; C Belka; U Ganswindt; M Henke; P Stegmaier; M Bamberg; S Welz; J Debus; A Gioules; A Voigt; G Volk; C Ohmann; T Wiegel; V Budach; M Stuschke; J Schipper; P A Gerber; W Budach
Journal: Strahlenther Onkol Date: 2013-07-05 Impact factor: 3.621

Treatment options in metastatic renal carcinoma: an embarrassment of riches.

1. New chemotherapy strategies and biological agents in the treatment of childhood ependymoma.

Review 2. [Uro-oncology--update 2009].

3. Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer.

4. Nanoliter droplet vitrification for oocyte cryopreservation.

5. Toward a common therapeutic framework in castration-resistant prostate cancer: a model for urologic oncology and medical oncology interaction.

6. Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck.

7. Overexpression of Numb suppresses growth, migration, and invasion of human clear cell renal cell carcinoma cells.

Review 8. Genomics of renal cell cancer-- does it provide breakthrough?

9. Immunological effects of multikinase inhibitors for kidney cancer: a clue for integration with cellular therapies?

Review 10. Comparing comparators: a look at control arms in kidney cancer studies over the years.